Valuation: Sysmex Corporation

Market Cap 1,253B 7.84B 7.1B 6.57B 5.93B 11.17B 739B 11.56B 78.91B 31.29B 395B 29.41B 28.78B P/E 2027 *
30.5x
P/E 2028 * 25.5x
Enterprise Value 1,273B 7.96B 7.22B 6.67B 6.02B 11.35B 751B 11.75B 80.17B 31.79B 401B 29.88B 29.25B EV / Sales 2027 *
2.33x
EV / Sales 2028 * 2.21x
Free-Float
71.34%
Yield 2027 *
1.94%
Yield 2028 * 2.02%
1 day+0.14%
1 week+0.75%
Current month+7.19%
1 month+11.31%
3 months+10.19%
6 months+55.07%
Current year+34.91%
1 week 2,050.5
Extreme 2050.5
2,227.5
1 month 1,815
Extreme 1815
2,227.5
Current year 1,246
Extreme 1246
2,227.5
1 year 1,246
Extreme 1246
2,227.5
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 77 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 77 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+0.75%+31.00%-17.71% 7.84B
+1.18%-1.28%-16.05%+13.29% 188B
+1.85%+1.04%+6.99%+42.70% 126B
-0.88%-4.98%-17.08%+9.86% 118B
+1.36%-5.91%-43.00%+3.16% 92.48B
+2.96%+7.64%-1.76%+80.54% 68.51B
+1.08%+2.90%+12.95%-7.56% 59.39B
+0.89%+4.17%+0.39%+62.87% 55.48B
-0.68%+6.83%-1.64%+55.26% 49.62B
-1.28%-0.43% - - 34.68B
Average +0.38%+0.59%-3.13%+26.93% 80B
Weighted average by Cap. +0.46%-0.39%-9.53%+26.78%

Financials

2027 *2028 *
Net sales 547B 3.42B 3.1B 2.87B 2.59B 4.87B 322B 5.05B 34.43B 13.65B 172B 12.83B 12.56B 577B 3.61B 3.27B 3.02B 2.73B 5.14B 340B 5.32B 36.31B 14.4B 182B 13.53B 13.25B
Net income 39.82B 249M 226M 209M 188M 355M 23.48B 367M 2.51B 994M 12.55B 935M 915M 49.64B 310M 281M 260M 235M 442M 29.27B 458M 3.13B 1.24B 15.64B 1.17B 1.14B
Net Debt 20.06B 125M 114M 105M 94.89M 179M 11.83B 185M 1.26B 501M 6.32B 471M 461M 18.61B 116M 105M 97.54M 88.01M 166M 10.97B 172M 1.17B 465M 5.86B 437M 427M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
26-11-13 ¥2,081.00 +0.14% 2,449,400
26-11-12 ¥2,078.00 +0.34% 3,153,300
26-11-11 ¥2,071.00 -2.63% 5,540,500
26-11-10 ¥2,127.00 -0.54% 4,198,800
26-11-09 ¥2,138.50 +3.53% 5,442,400
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,081.00JPY
Average target price
2,150.00JPY
Spread / Average Target
+3.32%
  1. Stock Market
  2. Stocks
  3. 6869 Stock